https://news.augustaheadlines.com/story/421932/maureen-m-petersen-md-launches-coaching-business-to-support-parents-of-chronically-ill-children.html 2023-05-04T20:03:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/422020/infliximab-biosimilar-landscape-report-2023-by-delveinsight.html 2023-05-04T20:00:04+00:00 daily 1.0 https://news.augustaheadlines.com/story/422019/germany-healthcare-outlook-report-2022-by-delveinsight-companies-fresenius-ag-bayer-ag-evotec-ag-boehringer-ingelheim-merck-kgaa-helios-kliniken-gmbh-sandoz-international-gmbh-symrise-ag.html 2023-05-04T19:58:01+00:00 daily 1.0 https://news.augustaheadlines.com/story/421931/matt-fed-teaching-how-anyone-can-achieve-health-and-wealth.html 2023-05-04T19:57:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/422018/spain-healthcare-outlook-report-2022-by-delveinsight-companies-mckinsey-spain-anaconda-biomed-asphalion-droplite-technologies-sl-genesis-biomed.html 2023-05-04T19:56:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/422017/complex-regional-pain-syndrome-crps-market-size-share-epidemiology-market-research-and-forecast-report-2032-companies-takeda-tryp-therapeutics-soin-therapeutics.html 2023-05-04T19:54:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/422016/sarcoidosis-market-research-report-epidemiology-and-competitive-insights-2032-companies-relief-therapeutics-holdings-atyr-pharma-amgen-bristolmyers-squibb-novartis-pfizer.html 2023-05-04T19:52:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/421930/dr-loukisha-preyear-debuts-a-company-focused-on-eradicating-workplace-bullying.html 2023-05-04T19:51:02+00:00 daily 1.0 https://news.augustaheadlines.com/story/422015/porphyria-market-size-share-epidemiology-and-competitive-analysis-report-2032-companies-clinuvel-pharmaceuticals-mitsubishi-tanabe-pharma-gilead-sciences-disc-medicine-atlas-molecular-pharma.html 2023-05-04T19:50:03+00:00 daily 1.0 https://news.augustaheadlines.com/story/422014/persistent-epithelial-defect-ped-market-size-share-epidemiology-and-competitive-landscape-report-2032-companies-dompe-farmaceutici-ocunexus-therapeutics-eyevance-pharmaceuticals.html 2023-05-04T19:48:03+00:00 daily 1.0